Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Holding RMD?
Track your performance easily
RMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$162.18 - $260.49
Previous Close$244.76
Volume505.87K
Average Volume (3M)977.70K
Market Cap
$35.93B
Enterprise Value$36.35B
Total Cash (Recent Filing)$426.36M
Total Debt (Recent Filing)$850.24M
Price to Earnings (P/E)32.4
Beta1.27
Next Earnings
Jan 23, 2025EPS Estimate
$2.32Last Dividend Ex-Date
Nov 07, 2024Dividend Yield0.84%
Share Statistics
EPS (TTM)7.54
Shares Outstanding146,795,746
10 Day Avg. Volume719,787
30 Day Avg. Volume977,704
Standard Deviation0.09
R-Squared0.16
Alpha0.00498
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)6.92
Price to Sales (P/S)7.37
Price to Cash Flow (P/CF)27.20
P/FCF Ratio29.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.71
Enterprise Value/Gross Profit13.69
Enterprise Value/Ebitda25.20
Forecast
1Y Price Target
$247.14Price Target Upside0.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Resmed News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceResMed achieved better-than-expected results with 11% revenue growth and 34% EPS growth, indicating strong financial performance.
Market PositionThe expansion of AirSense 11 rollout is contributing to ResMed gaining market share and enhancing its market position.
Strategic GrowthThe company's 2030 Plan outlines a path towards high-single digit revenue growth with earnings growth above revenue growth, implying sustainable double-digit earnings growth is achievable.
Bears Say
Market CompetitionPHG's re-entrance and GLP-1's remain overhangs and downside risks to revenue estimates.
Regulatory RiskLilly’s launch of an obstructive sleep apnea (OSA) indication for its GLP-1 medication tirzepatide poses significant patient funnel disruption/distortion risks.
ValuationShares appear 'priced to perfection' with a +30% move since Q2 lows, which might lead to profit-taking.
---
Ownership Overview
0.71% Insiders
16.46% Mutual Funds
9.94% Other Institutional Investors
49.75% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMD FAQ
What was Resmed’s price range in the past 12 months?
Resmed lowest stock price was $162.18 and its highest was $260.49 in the past 12 months.
What is Resmed’s market cap?
Currently, no data Available
When is Resmed’s upcoming earnings report date?
Resmed’s upcoming earnings report date is Jan 23, 2025 which is in 30 days.
How were Resmed’s earnings last quarter?
Resmed released its earnings results on Oct 24, 2024. The company reported $2.2 earnings per share for the quarter, beating the consensus estimate of $2.054 by $0.146.
Is Resmed overvalued?
According to Wall Street analysts Resmed’s price is currently Undervalued.
Does Resmed pay dividends?
Resmed pays a Quarterly dividend of $0.529 which represents an annual dividend yield of 0.84%. See more information on Resmed dividends here
What is Resmed’s EPS estimate?
Resmed’s EPS estimate is $2.32.
How many shares outstanding does Resmed have?
Resmed has 146,795,750 shares outstanding.
What happened to Resmed’s price movement after its last earnings report?
Resmed reported an EPS of $2.2 in its last earnings report, beating expectations of $2.054. Following the earnings report the stock price went up 7.123%.
Which hedge fund is a major shareholder of Resmed?
Among the largest hedge funds holding Resmed’s share is Greenvale Capital LLP. It holds Resmed’s shares valued at 171M.
---
Resmed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$247.14 (0.78% Upside)
$247.14 (0.78% Upside)
Blogger Sentiment
Bullish
RMD Sentiment 90%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 346.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
51.68%
12-Months-Change
Fundamentals
Return on Equity
23.56%
Trailing 12-Months
Asset Growth
7.14%
Trailing 12-Months
Company Description
Resmed
Founded in 1989, California-based ResMed, Inc. is a medical equipment company. The company is engaged in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through two segments: Sleep and Respiratory Care, and SaaS (Software as a Service).
---
RMD Company Deck
---
RMD Earnings Call
Q1 2024
0:00 / 0:00
---
RMD Revenue Breakdown
52.16% Devices
35.37% Masks and other
12.47% Software as a Service
---
RMD Stock 12 Month Forecast
Average Price Target
$247.14
▲(0.78% Upside)
Technical Analysis
Best Analysts Covering RMD
1 Year
1 Year Success Rate
13/19 ratings generated profit
1 Year Average Return
+14.72%
assigned a buy rating 2 months ago
Copying Lyanne Harrison's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +14.72% per trade.
---